Drug Database
Back to search

Belgium· BE-AMP-SAM246757-00

Tamiflu 75 mg

A oseltamivir product containing oseltamivir phosphate, registered in Belgium by Roche Registration. The same ATC class is registered in 16 of our 19 countries.

ATC J05AH02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTamiflu 75 mgATCJ05AH02REGISTER NO.BE-AMP-SAM246757-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oseltamivir phosphateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oseltamivir is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AH02 (oseltamivir), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose
Search oseltamivir products by name

Oseltamivir · ATC J05AH02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Oseltamivir Phosphate
Manufacturer
Roche Registration
Country
Belgium (BE)
ATC code
J05AH02
ATC class
Oseltamivir
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1691625

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

93 interactions on record for oseltamivir.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oseltamivir against other medicinesHow interaction checks work

Oseltamivir · interactions on record

93 records

  • 4 moderate
  • 1 minor
  • 88 info

Most severe, free to view

  • MethotrexateL01BA01moderate
  • PemetrexedL01BA04moderate
  • MethotrexateL04AX03moderate
  • MethotrexatM01CX01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oseltamivir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oseltamivir products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Bulgaria · Бетафлу
  • Germany · Oseltamivir Hec Pharm, Oseltamivir Stada
  • Estonia · Segosana
  • Spain · Oseltamivir Accord
  • France · Oseltamivir Zentiva
  • United Kingdom (Northern Ireland) · Oseltamivir, Oseltamivir Accord-Uk
  • Hungary · Segosana
  • Iceland · Ebilfumin, Tamiflu
  • Liechtenstein · Ebilfumin, Tamiflu
  • Lithuania · Segosana
  • Latvia · Segosana
  • Netherlands · Oseltamivir Zentiva, Segosana
  • Norway · Ebilfumin, Tamiflu
  • Poland · Griptavir Med, Oseltamivir Stada
  • Romania · Oseltamivir Accord, Oseltamivir Laropharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b0ce9900-49ec-41fc-ae21-79bb00931f78
GET /v1/drugs/b0ce9900-49ec-41fc-ae21-79bb00931f78?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tamiflu 75 mg",
  "name_fr": "Tamiflu 75 mg",
  "name_nl": "Tamiflu 75 mg",
  "amp_code": "SAM246757-00",
  "strengths": [
    "75.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Oseltamivir Phosphate",
    "Oseltamivir"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Oseltamivir",
  "authorisation_numbers": [
    "EU/1/02/222/001"
  ]
}
API referenceMCP serverPlans

See everything about oseltamivir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console